Month: March 2022

First data showing OCREVUS treatment effect on disability progression in non-active secondary progressive multiple sclerosis and further data in primary progressive MS will be presented Evrysdi data continue to demonstrate long-term efficacy and safety in a broad population of people with spinal muscular atrophy Longer-term efficacy and safety for Enspryng in neuromyelitis optica spectrum disorder reinforce previously seen results Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatmentBasel, 25 March 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new data for its approved and investigational medicines across neurological disorders will be presented at the 74th American Academy of Neurology...

*** Unofficial English translation – For convenience purposes only *** UCB SA/NV – Public Limited Liability CompanyAllée de la Recherche 60, 1070 BrusselsEnterprise nr. 0403.053.608 (RLE Brussels)www.ucb.com(“UCB SA/NV” or the “Company”)  CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS   The Board of Directors invites the shareholders for the ordinary and extraordinary general meeting of shareholders (the “General Meeting”) which will be held on Thursday, 28 April 2022, at 11:00 am CEST, at the registered office of UCB SA/NV, Allée de la Recherche 60 – 1070 Brussels, for the purpose of considering and voting on the items shown on the agenda set out below. Depending on the evolution of the Covid-19 pandemic and the related measures taken by our governments and public authorities, we may need to further...

GUADALAJARA, Mexico, March 25, 2022 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (the “Company” or “GAP”) informs that today was held the Investor Day 2022 (GAP DAY) at the Tijuana International Airport. The Company’s executives shared with investors, analysts, and other related parties, the short- and long-term strategies of the Company, as well as financial expectations. The GAP DAY 2022 presentation is available on the Company’s website in the Investors section. https://www.aeropuertosgap.com.mx/files/GAP_DAY_2022_VF.pdf * * * Company Description:Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (GAP) operates 12 airports throughout Mexico’s Pacific region, including the major cities of Guadalajara and Tijuana, the four tourist destinations of Puerto Vallarta, Los Cabos,...

COPENHAGEN, Denmark, March 24, 2022 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to create new product candidates that address unmet medical needs, today announced the pricing of its offering of US$500,000,000 aggregate principal amount of 2.25% convertible senior notes due 2028 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes are scheduled to settle on March 29, 2022, subject to the satisfaction of customary closing conditions. Ascendis Pharma also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes...

MENLO PARK, Calif., March 24, 2022 (GLOBE NEWSWIRE) — AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced the pricing of its upsized initial public offering of 4,600,000 shares of its common stock at a price to the public of $15.00 per share. All of the shares of common stock are being offered by AN2 Therapeutics. The gross proceeds to AN2 Therapeutics from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by AN2 Therapeutics, are expected to be $69.0 million. In addition, AN2 Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares of common stock at the initial public offering price, less...

BEIJING, March 24, 2022 (GLOBE NEWSWIRE) — JD.com, Inc. (“JD.com”) (Nasdaq: JD; HKEx: 9618), a leading supply chain-based technology and service provider, today announced that JD Logistics, Inc. (“JD Logistics”) (HKEx: 2618), a consolidated subsidiary of JD.com, has entered into a placing agreement, pursuant to which JD Logistics has agreed to issue 150,500,000 of its ordinary shares to a group of third-party investors for a total purchase price of approximately US$398 million in a placement (the “JDL Placement”). Concurrently, JD.com, through its wholly-owned subsidiary (the “JD Entity”), has entered into a subscription agreement with JD Logistics, pursuant to which the JD Entity has agreed to subscribe for, and JD Logistics has agreed to issue, 261,400,000 ordinary shares of JD Logistics, at the same per share price for the JDL...

Amsterdam (Netherlands), March 24, 2022 – STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, published today its IFRS 2021 Annual Report for the twelve-month period ended December 31, 2021 on its website, and filed it with the Netherlands Authority for the Financial Markets (AFM). The Annual Report, prepared in accordance with International Financial Reporting Standards (IFRS-EU) and a complete audited financial statement, is now available on www.st.com, and will be available on www.afm.nl. A hard copy version of the Annual Report will be available free of charge from ST’s Investor Relations Department: +41 22 929 5920 or www.investors.st.com. The Supervisory Board has decided to propose at the Company’s 2022 Annual General Meeting of Shareholders the distribution...

The Fluence Gridstack Energy Storage System Fluence to deliver a 50 MW / 50 MWh Gridstack energy storage system to AGL.MELBOURNE, Australia, March 24, 2022 (GLOBE NEWSWIRE) — Fluence (NASDAQ: FLNC), a global market leader in energy storage products and services and digital applications for renewables and storage announced today that it has been chosen by AGL to deliver a 50 MW / 50 MWh energy storage system with advanced grid-forming capabilities for Broken Hill Battery Energy Storage System, an ARENA-funded battery project. The project will use Fluence’s Gridstack™ product and contribute to AGL’s planned 850 MW national battery rollout and demonstrate the capability of latest inverter technology to support stable operation in areas of low system strength. The effective partnership between AGL, ARENA, UNSW and Fluence has enabled...